je.st
news
Biotech IPOs Slow to Trickle as Stock Rout Rattles Investors
2015-10-08 20:25:02| Biotech - Topix.net
The biotechnology sector's two-and-a-half-year deluge of public market debuts, with dozens of companies raising billions of dollars in funding, is now down to a trickle. After CytomX Therapeutics Inc. priced its initial public offering late Wednesday, not a single biomedical, drug or therapeutics company is expected to follow suit in the next 30 days.
Tags: stock
slow
investors
ipos
Category:Biotechnology and Pharmaceuticals